PUBLISHER: Grand View Research | PRODUCT CODE: 1511986
PUBLISHER: Grand View Research | PRODUCT CODE: 1511986
The global veterinary anti-infectives market size is expected to reach USD 11.93 billion by 2030, registering a CAGR of 5.3% from 2024 to 2030, according to a new report by Grand View Research, Inc. One of the most promising market drivers is the growing application and utilization of artificial intelligence (AI) to solve challenges in the veterinary sector. These activities, apart from the broader veterinary sector, are also happening in the field of veterinary anti-infectives.
A May 2024 study published by the Chinese Academy of Sciences and Newcastle University employed AI to uncover existing research gaps in antimicrobial research in multiple sectors like veterinary, medical, food safety, and environment. The study highlighted an important roadblock: a lack of collaboration, mainly in low-middle-income countries, regarding inter-sectoral research and development. Initiatives like this will boost the market by providing advanced knowledge about resistive infectious pathogens and promoting multi-sectoral research and development to tackle these complications.
In January 2023, the University of Nottingham invested over USD 2.0 million into a research project on rising resistance among infectious pathogens. The research project aims to study various crucial factors of infectious pathogens affecting humans and animals, such as genetic makeup, molecular interaction, and drug resistance pathways, using AI to discover novel therapeutic agents.
These factors promote the adoption of novel technologies to address the existing challenges in the veterinary anti-infectives industry and discover solutions to tackle them effectively. For instance, using AI to understand the infectious pathogens affecting animals on a structural and physiological level will assist researchers in designing specific drugs to combat them.
The rise in the integration of human & veterinary research also drives the market. This will encourage inter-sectoral research to develop novel drugs like antibiotics, anti-infectives, and antifungals amidst the growing drug resistance.
In January 2023, a leading drugs database that monitors drug approvals and stores drug information, Drug Central, enhanced its directory by integrating more than 154 veterinary drugs. This platform has 396 veterinary drugs classified based on factors like active pharmaceutical ingredients (APIs), pharmacological classification, drug indications, inter-sectoral drug use between human and veterinary, drug bioactivity, OTC, and prescription.